Gene · 7170
Papers3,595
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 3,595
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
CRISPR-Based Activation of Endogenous Expression of TPM1 Inhibits Inflammatory Response of Primary Human Coronary Artery Endothelial and Smooth Muscle Cells Induced by Recombinant Human Tumor Necrosis Factor α. | Front Cell Dev Biol | 2021 | 34604206 | PubTator, text mining | PubMed |
| Ring finger protein 213 assembles into a sensor for ISGylated proteins with antimicrobial activity. | Nat Commun | 2021 | 34599178 | PubTator, text mining | PubMed |
| Constitutive signal bias mediated by the human GHRHR splice variant 1. | Proc Natl Acad Sci U S A | 2021 | 34599099 | PubTator, text mining | PubMed |
| Utility of comprehensive genomic profiling in directing treatment and improving patient outcomes in advanced non-small cell lung cancer. | BMC Med | 2021 | 34592968 | PubTator, text mining | PubMed |
| EML4-ALK Rearrangement as a Mechanism of Resistance to Osimertinib in Metastatic Lung Adenocarcinoma: A Case Report. | JTO Clin Res Rep | 2021 | 34590027 | PubTator, text mining | PubMed |
| Correlating ROS1 Protein Expression With ROS1 Fusions, Amplifications, and Mutations. | JTO Clin Res Rep | 2021 | 34589979 | PubTator, text mining | PubMed |
| Efficacy of Taletrectinib (AB-106/DS-6051b) in ROS1+ NSCLC: An Updated Pooled Analysis of U.S. and Japan Phase 1 Studies. | JTO Clin Res Rep | 2021 | 34589973 | PubTator, text mining | PubMed |
| Identification and evaluation of fructose-bisphosphate aldolase B as a potential diagnostic biomarker in choledochal cysts patients: a quantitative proteomic analysis. | Transl Pediatr | 2021 | 34584879 | PubTator, text mining | PubMed |
| Cryo-EM structure of the sodium-driven chloride/bicarbonate exchanger NDCBE. | Nat Commun | 2021 | 34584093 | PubTator, text mining | PubMed |
| A systematic bioinformatics approach for large-scale identification and characterization of host-pathogen shared sequences. | BMC Genomics | 2021 | 34583643 | PubTator, text mining | PubMed |
| Specific Engineered G Protein Coupling to Histamine Receptors Revealed from Cellular Assay Experiments and Accelerated Molecular Dynamics Simulations. | Int J Mol Sci | 2021 | 34576210 | PubTator, text mining | PubMed |
| The miR-133a, TPM4 and TAp63γ Role in Myocyte Differentiation Microfilament Remodelling and Colon Cancer Progression. | Int J Mol Sci | 2021 | 34575979 | PubTator, text mining | PubMed |
| Gene Duplication and Gene Fusion Are Important Drivers of Tumourigenesis during Cancer Evolution. | Genes (Basel) | 2021 | 34573358 | PubTator, text mining | PubMed |
| Molecular Biology Networks and Key Gene Regulators for Inflammatory Biomarkers Shared by Breast Cancer Development: Multi-Omics Systems Analysis. | Biomolecules | 2021 | 34572592 | PubTator, text mining | PubMed |
| Allosteric Modulators Enhancing GLP-1 Binding to GLP-1R via a Transmembrane Site. | ACS Chem Biol | 2021 | 34570476 | PubTator, text mining | PubMed |
| Structures of active melanocortin-4 receptor-Gs-protein complexes with NDP-α-MSH and setmelanotide. | Cell Res | 2021 | 34561620 | PubTator, text mining | PubMed |
| Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer (Review). | Int J Oncol | 2021 | 34558640 | PubTator, text mining | PubMed |
| Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors. | Innovation (Camb) | 2021 | 34557754 | PubTator, text mining | PubMed |
| Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia. | Cell Rep | 2021 | 34551306 | PubTator, text mining | PubMed |
| Structures and Agonist Binding Sites of Bitter Taste Receptor TAS2R5 Complexed with Gi Protein and Validated against Experiment. | J Phys Chem Lett | 2021 | 34542294 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7170/papers?page=52